Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904. https://doi.org/10.1038/nm1469.

Article  CAS  PubMed  Google Scholar 

Soelch S, Beaufort N, Loessner D, Kotzsch M, Reuning U, Luther T, et al. Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells. Mol Med. 2021;27(1):158. https://doi.org/10.1186/s10020-021-00419-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HS, Tian L, Jung M, Choi SK, Sun Y, Kim H, et al. Downregulation of choline kinase-alpha enhances autophagy in tamoxifen-resistant breast cancer cells. PLoS ONE. 2015;10(10): e0141110. https://doi.org/10.1371/journal.pone.0141110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Anta JM, Mayo C, Solé F, Salido M, Espinet B, Corzo C, et al. Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment. Int J Cancer. 2006;119(7):1607–15. https://doi.org/10.1002/ijc.22028.

Article  CAS  PubMed  Google Scholar 

Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–22. https://doi.org/10.1038/nrc3793.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willis RA. The spread of tumours in the human body. Nature. 1934;133:743–743. https://doi.org/10.1038/133743c0.

Article  Google Scholar 

Hadfield G. The dormant cancer cell. Br Med J. 1954;2:607–10. https://doi.org/10.1136/bmj.2.4888.607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Easwaran S, Montell DJ. The molecular mechanisms of diapause and diapause-like reversible arrest. Biochem Soc Trans. 2023;51(5):1847–56. https://doi.org/10.1042/BST20221431.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao J, Zhang Z, Zhou L, Luo M, Li L, Li B, et al. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. MedComm. 2020;4(6):e427. https://doi.org/10.1002/mco2.427.

Article  PubMed  PubMed Central  Google Scholar 

Dhimolea E, de Matos SR, Kansara D, Al’Khafaji A, Bouyssou J, Weng X, et al. An embryonic diapause-like adaptation with suppressed myc activity enables tumor treatment persistence. Cancer Cell. 2021;39(2):240-256.e11. https://doi.org/10.1016/j.ccell.2020.12.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mikubo M, Inoue Y, Liu G, Tsao MS. Mechanism of drug tolerant persister cancer cells: the landscape and clinical implication for therapy. J Thorac Oncol. 2021;16(11):1798–809. https://doi.org/10.1016/j.jtho.2021.07.017.

Article  CAS  PubMed  Google Scholar 

Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20(7):398–411. https://doi.org/10.1038/s41568-020-0263-0.

Article  CAS  PubMed  Google Scholar 

Keeratichamroen S, Sornprachum T, Ngiwsara L, Ornnork N, Svasti J. p-STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model. Oncol Rep. 2023;49(4):71. https://doi.org/10.3892/or.2023.8508.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang D, Sun H, Wei J, Cen B, DuBois RN. CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer. Cancer Res. 2017;77(13):3655–65. https://doi.org/10.1158/0008-5472.CAN-16-3199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyden D, Ghajar CM, Correia AL, Aguirre-Ghiso JA, Cai S, Rescigno M, et al. Metastasis. Cancer Cell. 2022;40(8):787–91. https://doi.org/10.1016/j.ccell.2022.07.010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McGrath J, Panzica L, Ransom R, Withers HG, Gelman IH. Identification of genes regulating breast cancer dormancy in 3D bone endosteal niche cultures. Mol Cancer Res. 2019;17(4):860–9. https://doi.org/10.1158/1541-7786.Mcr-18-0956.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawson MA, McDonald MM, Kovacic N, Hua Khoo W, Terry RL, Down J, et al. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun. 2015;6:8983. https://doi.org/10.1038/ncomms9983.

Article  CAS  PubMed  Google Scholar 

Khoo WH, Ledergor G, Weiner A, Roden DL, Terry RL, McDonald MM, et al. A niche-dependent myeloid transcriptome signature defines dormant myeloma cells. Blood. 2019;134(1):30–43. https://doi.org/10.1182/blood.2018880930.

Article  CAS  PubMed  Google Scholar 

Pradhan S, Slater JH. Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation. Biomaterials. 2019;215:119177. https://doi.org/10.1016/j.biomaterials.2019.04.022.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010;141(1):69–80. https://doi.org/10.1016/j.cell.2010.02.027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS biol. 2006;4(3):e83. https://doi.org/10.1371/journal.pbio.0040083.

Article  PubMed  PubMed Central  Google Scholar 

Adam AP, George A, Schewe D, Bragado P, Iglesias BV, Ranganathan AC, et al. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 2009;69(14):5664–72. https://doi.org/10.1158/0008-5472.Can-08-3820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pelizzo G, Riva F, Croce S, Avanzini MA, Acquafredda G, de Silvestri A, et al. Proliferation pattern of pediatric tumor-derived mesenchymal stromal cells and role in cancer dormancy: a perspective of study for surgical strategy. Front Pediatr. 2021;9:766610. https://doi.org/10.3389/fped.2021.766610.

Article  PubMed  PubMed Central  Google Scholar 

Pranzini E, Raugei G, Taddei ML. Metabolic features of tumor dormancy: possible therapeutic strategies. Cancers (Basel). 2022;14(3):547. https://doi.org/10.3390/cancers14030547.

Article  PubMed  Google Scholar 

Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharmacol Sci. 2019;40(2):128–41. https://doi.org/10.1016/j.tips.2018.12.004.

Article  CAS  PubMed  Google Scholar 

Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522–6. https://doi.org/10.1038/nature11287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, et al. Melanoma models for the next generation of therapies. Cancer Cell. 2021;39(5):610–31. https://doi.org/10.1016/j.ccell.2021.01.011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Payne KK, Keim RC, Graham L, Idowu MO, Wan W, Wang XY, et al. Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells. J Leukoc Biol. 2016;100(3):625–35. https://doi.org/10.1189/jlb.5A1215-580R.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–70. https://doi.org/10.1126/science.1203486.

Article  CAS  PubMed  Google Scholar 

Cole K, Al-Kadhimi Z, Talmadge JE. Role of myeloid-derived suppressor cells in tumor recurrence. Cancer Metasta Rev. 2023;42(1):113–42. https://doi.org/10.1007/s10555-023-10079-1.

Article  CAS  Google Scholar 

Mukherjee A, Bravo-Cordero JJ. Regulation of dormancy during tumor dissemination: the role of the ECM. Cancer Metasta Rev. 2023;42(1):99–112. https://doi.org/10.1007/s10555-023-10094-2.

Article  Google Scholar